![Benoît Pastour](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benoît Pastour
Corporate Officer/Principal bei
ALTUR INVESTISSEMENT
Profil
Benoît Pastour currently works at Nord Capital Partenaires SAS, as Chief Executive Officer from 2010, Turenne Capital Partenaires SA, as Managing Director from 2016, Aterovax SA, as Director from 2013, and Altur Investissement SCA, as Executive Vice President.
Mr. Pastour also formerly worked at Vauban Partenaires SA, as Director-Participations from 1991 to 2007, DNA Therapeutics SASU, as Director, Biom'Up SA, as Director, and UniCredit SpA, as Head-LBO Financing.
Mr. Pastour received his graduate degree from Université Paris 1 Panthéon-Sorbonne and graduate degree from IÉSEG School of Management.
Aktive Positionen von Benoît Pastour
| Unternehmen | Position | Beginn |
|---|---|---|
| ALTUR INVESTISSEMENT | Corporate Officer/Principal | 08.03.2011 |
Turenne Capital Partenaires SA
 Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million. | Private Equity Investor | 01.03.2008 |
Nord Capital Partenaires SAS
 Nord Capital Partenaires SAS Investment ManagersFinance Nord Capital Partenaires invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing for buyout and growth capital requirements with an investment size of EUR 1 -10 million. | Vorstandsvorsitzender | 12.11.2010 |
Aterovax SA
 Aterovax SA Medical/Nursing ServicesHealth Services Develops in vitro diagnostic products | Direktor/Vorstandsmitglied | 03.09.2013 |
Ehemalige bekannte Positionen von Benoît Pastour
| Unternehmen | Position | Ende |
|---|---|---|
Vauban Partenaires SA
 Vauban Partenaires SA Investment ManagersFinance VP is a regional private equity firm specialized in small and medium-sized companies with 3 to 200 million Euros in turnover. The firm invests across sectors in profitable businesses and targets situations including LBO, MBO, OBO and shareholder restructuration. They also participate in expansion financing. VP has a medium-term investment horizon, actively participates in strategic decisions and promotes acquisitions. Their regional focus covers Nord-Pas de Calais, Picardy, Normandy, the Loire Valley, Auvergne and Limousin. | Mitglied des Investmentausschusses | 01.12.2007 |
| BIOM'UP | Direktor/Vorstandsmitglied | - |
DNA Therapeutics SASU
 DNA Therapeutics SASU BiotechnologyHealth Technology Engages in the development of drugs for cancer treatment | Direktor/Vorstandsmitglied | - |
| UNICREDIT S.P.A. | Corporate Officer/Principal | - |
Ausbildung von Benoît Pastour
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Turenne Capital Partenaires SA
Turenne Capital Partenaires SA Investment ManagersFinance Turenne Capital invests in small and middle market companies located in France. The firm focuses on healthcare, hospitality, environment, energetic transition and innovacom sectors. It participates in seed, early and later stage transactions with an investment size of less than EUR 30 million. | Finance |
Université Paris 1 Panthéon-Sorbonne
 Université Paris 1 Panthéon-Sorbonne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vauban Partenaires SA
Vauban Partenaires SA Investment ManagersFinance VP is a regional private equity firm specialized in small and medium-sized companies with 3 to 200 million Euros in turnover. The firm invests across sectors in profitable businesses and targets situations including LBO, MBO, OBO and shareholder restructuration. They also participate in expansion financing. VP has a medium-term investment horizon, actively participates in strategic decisions and promotes acquisitions. Their regional focus covers Nord-Pas de Calais, Picardy, Normandy, the Loire Valley, Auvergne and Limousin. | Finance |
Altur Investissement SCA
 Altur Investissement SCA Investment ManagersFinance Acts as Private Equity Fund | Finance |
UniCredit SpA
 UniCredit SpA Major BanksFinance Operates as a pan-European commercial bank | Finance |
DNA Therapeutics SASU
DNA Therapeutics SASU BiotechnologyHealth Technology Engages in the development of drugs for cancer treatment | Health Technology |
Biom'Up SA
 Biom'Up SA Medical SpecialtiesHealth Technology Manufactures medical devices based on collagen technology | Health Technology |
Nord Capital Partenaires SAS
Nord Capital Partenaires SAS Investment ManagersFinance Nord Capital Partenaires invests in companies located in France. The firm focuses on a broad range of sectors and industries. It provides financing for buyout and growth capital requirements with an investment size of EUR 1 -10 million. | Finance |
Aterovax SA
Aterovax SA Medical/Nursing ServicesHealth Services Develops in vitro diagnostic products | Health Services |
IÉSEG School of Management
 IÉSEG School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
